The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Sodium Intake, ACE Inhibition, and Progression to ESRD
Open accessAbstract
High sodium intake limits the antihypertensive and antiproteinuric effects of angiotensin-converting enzyme (ACE) inhibitors in patients with CKD; however, whether dietary sodium also associates with progression to ESRD is unknown. We conducted a post hoc analysis of the first and second Ramipril Efficacy in Nephropathy trials to evaluate the association of sodium intake with proteinuria and progression to ESRD among 500 CKD patients without diabetes who were treated with ramipril (5 mg/d) and monitored with serial 24-hour urinary sodium and creatinine measurements. Urinary sodium/creatinine excretion defined low (<100 mEq/g), medium (100 to <200 mEq/g), and high (≥200 mEq/g) sodium intake. During a follow-up of >4.25 years, 92 individuals (18.4%) developed ESRD. Among those with low, medium, and high sodium intakes, the incidence of ESRD was 6.1 (95% confidence interval [95% CI], 3.8-9.7), 7.9 (95% CI, 6.1-10.2), and 18.2 (95% CI, 11.3-29.3) per 100 patient-years, respectively (P<0.001). Patients with high dietary sodium exhibited a blunted antiproteinuric effect of ACE inhibition despite similar BP among groups. Each 100-mEq/g increase in urinary sodium/creatinine excretion associated with a 1.61-fold (95% CI, 1.15-2.24) higher risk for ESRD; adjusting for baseline proteinuria attenuated this association to 1.38-fold (95% CI, 0.95-2.00). This association was independent from BP but was lost after adjusting for changes in proteinuria. In summary, among patients with CKD but without diabetes, high dietary salt (>14 g daily) seems to blunt the antiproteinuric effect of ACE inhibitor therapy and increase the risk for ESRD, independent of BP control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Self-citationRose, G. A., Stamler, J., Stamler, R., Elliott, P., Marmot, M. G., Pyörälä, K., Kesteloot, H., Joossens, J. V., Hansson, L. ‐., Mancia, G., et al. (1988) · Cited by 1,281
Stamler, R., Nissinen, A. M., Uusitalo, U. M., Rose, G., Pietinen, P., & Stamler, J. (1988) · Cited by 1,042
Ruggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910
Self-citationPyMC: Bayesian Stochastic Modelling in Python
Patil, A., Huard, D., & Fonnesbeck, C. (2010) · Journal of Statistical Software · doi:10.18637/jss.v035.i04 · Cited by 711
Ruggenenti, P., Perna, A., Loriga, G., Ganeva, M., Ene-Iordache, B., Turturro, M., Lesti, M., Perticucci, E., Chakarski, I. N., Leonardis, D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71082-5 · Cited by 644
Self-citationRuggenenti, P., Perna, A., Gherardi, G., Gaspari, F., Benini, R., & Remuzzi, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04433-x · Cited by 574
Self-citationJM: An R Package for the Joint Modelling of Longitudinal and Time-to-Event Data
Rizopoulos, D. (2010) · Journal of Statistical Software · doi:10.18637/jss.v035.i09 · Cited by 486
Frost, C. D., Law, M. R., & Wald, N. J. (1991) · BMJ · doi:10.1136/bmj.302.6780.815 · Cited by 399
Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan
Vogt, L., Waanders, F., Boomsma, F., de Zeeuw, D., & Navis, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060693 · Cited by 372
Self-citationSlagman, M. C. J., Waanders, F., Hemmelder, M. H., Woittiez, A.-J., Janssen, W. M. T., Lambers Heerspink, H. J., Navis, G., Laverman, G. D., & for the HONEST (HOlland NEphrology STudy) Group (2011) · BMJ · doi:10.1136/bmj.d4366 · Cited by 286
Self-citationRetarding progression of chronic renal disease: The neglected issue of residual proteinuria
Ruggenenti, P., Perna, A., Remuzzi, G., & Investigators of the Gisen Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00033.x · Cited by 279
Self-citationSchjoedt, K. J., Andersen, S., Rossing, P., Tarnow, L., & Parving, H.-H. (2004) · Diabetologia · doi:10.1007/s00125-004-1542-0 · Cited by 249
Dietary sodium and target organ damage in essential hypertension
du Cailar, G. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02287-7 · Cited by 230
Sodium intake affects urinary albumin excretion especially in overweight subjects
Verhave, J. C., Hillege, H. L., Burgerhof, J. G. M., Janssen, W. M. T., Gansevoort, R. T., Navis, G. J., de Zeeuw, D., de Jong, P. E., & The PREVEND study group (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01390.x · Cited by 208
Self-citationRole of Remission Clinics in the Longitudinal Treatment of CKD
Ruggenenti, P., Perticucci, E., Cravedi, P., Gambara, V., Costantini, M., Sharma, S. K., Perna, A., & Remuzzi, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007090970 · Cited by 204
Self-citationButer, H. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.7.1682 · Cited by 199
Swift, P. A., Markandu, N. D., Sagnella, G. A., He, F. J., & MacGregor, G. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000172662.12480.7f · Cited by 170
Salt Intake and Renal Outcome in Patients with Progressive Renal Disease
Cianciaruso, B., Bellizzi, V., Minutolo, R., A, T., Capuano, A., Conte, G., & Nicola, L. D. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057385 · Cited by 155
A Low-Sodium Diet Potentiates the Effects of Losartan in Type 2 Diabetes
Houlihan, C. A., Allen, T. J., Baxter, A. L., Panangiotopoulos, S., CASLEY, D. J., Cooper, M. E., & Jerums, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.663 · Cited by 142
Nicola, L. D., Minutolo, R., Chiodini, P., Zoccali, C., Castellino, P., Donadio, C., Strippoli, M., Casino, F. G., Giannattasio, M., Petrarulo, F., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000085 · Cited by 135
Benefits of dietary sodium restriction in the management of chronic kidney disease
Krikken, J. A., Laverman, G. D., & Navis, G. J. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283312fc8 · Cited by 120
Self-citationAldosterone Blockade: An Emerging Strategy for Abrogating Progressive Renal Disease
Epstein, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.038 · Cited by 119
Ruggenenti, P. L., Bettinaglio, P., Pinares, F., & Remuzzi, G. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04140907 · Cited by 114
Self-citationKrikken, J. A., Lely, A. T., Bakker, S. J. L., & Navis, G. J. (2006) · Kidney International · doi:10.1038/sj.ki.5002011 · Cited by 100
Self-citationAllen, T. J., Waldron, M. J., CASLEY, D. J., Jerums, G., & Cooper, M. E. (1997) · Diabetes · doi:10.2337/diab.46.1.119 · Cited by 79
Late escape from the antiproteinuric effect of ACE inhibitors in nondiabetic renal disease
Shiigai, T., & Shichiri, M. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80003-2 · Cited by 70
DE'OLIVEIRA, J. M. F., Price, D. A., Fisher, N. D. L., Allan, D. R., McKnight, J. A., Williams, G. H., & Hollenberg, N. K. (1997) · Kidney International · doi:10.1038/ki.1997.394 · Cited by 68
Lakkis, J. I., Lu, W. X., & Weir, M. R. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0087-9 · Cited by 68
Ekinci, E. I., Thomas, G., Thomas, D. M., Johnson, C., MacIsaac, R. J., Houlihan, C. A., Finch, S. J., Panagiotopoulos, S., O’Callaghan, C. J., & Jerums, G. (2009) · Diabetes Care · doi:10.2337/dc08-2297 · Cited by 63
Allen, T. J., Waldron, M. J., CASLEY, D. J., Jerums, G., & Cooper, M. E. (1997) · Diabetes · doi:10.2337/diabetes.46.1.19 · Cited by 63
Logical and statistical fallacies in the use of cox regression models
Wolfe, R. A., & Strawderman, R. L. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90039-6 · Cited by 55
Reproducibility of salt sensitivity testing using a dietary approach in essential hypertension
Gerdts, E., Lund‐Johansen, P., & Omvik, P. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000814 · Cited by 28
Cited by
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Gansevoort, R. T., Correa-Rotter, R., Hemmelgarn, B. R., Jafar, T. H., Heerspink, H. J. L., Mann, J. F., Matsushita, K., & Wen, C. P. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60595-4 · Cited by 2,213
KDOQI clinical practice guideline for nutrition in CKD: 2020 update
Ikizler, T. A., Burrowes, J. D., Byham-Gray, L. D., Campbell, K. L., Carrero, J.-J., Chan, W., Fouque, D., Friedman, A. N., Ghaddar, S., Goldstein-Fuchs, D. J., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.006 · Cited by 1,960
Update of pathophysiology and management of diabetic kidney disease
Lin, Y.-C., Chang, Y.-H., Yang, S.-Y., Wu, K.-D., & Chu, T.-S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.02.007 · Cited by 562
Urea and Ammonia Metabolism and the Control of Renal Nitrogen Excretion
Weiner, I. D., Mitch, W. E., & Sands, J. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10311013 · Cited by 492
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
on behalf of the European Kidney Health Alliance, Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J. J., Lameire, N., Morton, R. L., Oberbauer, R., Postma, M. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.63 · Cited by 368
Self-citation
Metadata
- Authors
- Vegter, S., Perna, A., Postma, M. J., Navis, G., Remuzzi, G., & Ruggenenti, P.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-01
- Volume
- 23
- Issue
- 1
- Pages
- 165-173
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2105978370
- Cited by
- 305
- References
- 37
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.